| Offering Information |
| Expected Date | - |
| Proposed Exchange/Ticker |
Nasdaq: IMMC |
| Security Type |
Common Stock |
| Lead Underwriter |
UBS Investment Bank |
| Days In Registration |
130 |
| Date Filed |
8-Dec-2003 |
| Form Filed | S-1 |
Fundamentals
(Year Ending December 2008) |
| Industry |
Manufacturing |
| Business Description |
Develop magnetic nanoparticles or ferrofluids, and devices for magnetic collection, manufacture and markets ultra-high sensitive cancer detection test kits (Cancer Blood Test) and next generation cell analysis instruments (Cell Track Cytometer) for various research and clinical applications. |
| Revenue |
- |
| Net Income |
- |
| Shares Outstanding (post-offering) |
22.83M |
| Contact |
- |
| Number of Employees |
- |
|
| Original Filing Information |
| US |
| Shares Filed |
6.0M |
| Secondary Shares Filed | - |
| · As a Percent |
- |
| Primary Shares Filed |
6.0M |
| · As a Percent |
100.0 |
| Overallotment Shares Filed |
900.0K |
| File Amount |
$78.0M |
| File Price Range |
$14.00 - $12.00 |
| File Mid Price |
$13.00 |
Current Filing Information
(Amended 15-Apr-2004) |
|
US |
|
Shares Filed |
6.0M |
| Secondary Shares Filed |
- |
| · As a Percent |
- |
| Primary Shares Filed |
6.0M |
| · As a Percent |
100.0 |
| Overallotment Shares Filed |
- |
| File Amount |
$48.0M |
| · % Change from Original |
-38.46 |
| File Price Range |
$8.00 - $8.00 |
| File Mid Price |
$8.00 |
|
